Natixis Advisors LLC Has $7.61 Million Holdings in Bath & Body Works, Inc. $BBWI

Natixis Advisors LLC boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 18.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 378,827 shares of the company’s stock after buying an additional 59,342 shares during the quarter. Natixis Advisors LLC’s holdings in Bath & Body Works were worth $7,607,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of BBWI. Diamond Hill Capital Management Inc. grew its position in shares of Bath & Body Works by 29.9% in the third quarter. Diamond Hill Capital Management Inc. now owns 369,452 shares of the company’s stock valued at $9,517,000 after purchasing an additional 85,000 shares during the last quarter. Allianz Asset Management GmbH grew its position in shares of Bath & Body Works by 58.8% in the third quarter. Allianz Asset Management GmbH now owns 263,628 shares of the company’s stock valued at $6,791,000 after purchasing an additional 97,640 shares during the last quarter. SG Americas Securities LLC grew its position in shares of Bath & Body Works by 725.3% in the fourth quarter. SG Americas Securities LLC now owns 466,338 shares of the company’s stock valued at $9,364,000 after purchasing an additional 409,831 shares during the last quarter. Chase Investment Counsel Corp acquired a new position in shares of Bath & Body Works in the fourth quarter valued at approximately $1,606,000. Finally, Jupiter Asset Management Ltd. grew its position in shares of Bath & Body Works by 553.2% in the third quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock valued at $95,685,000 after purchasing an additional 3,145,797 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Wells Fargo & Company decreased their target price on Bath & Body Works from $29.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday, May 28th. Piper Sandler began coverage on Bath & Body Works in a research note on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target for the company. Deutsche Bank Aktiengesellschaft raised their price objective on Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Tuesday, March 3rd. Telsey Advisory Group lowered their price objective on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research note on Thursday, May 28th. Finally, UBS Group lowered their price objective on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 20th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and a consensus price target of $21.93.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $17.44 on Monday. The stock’s fifty day moving average price is $18.58 and its two-hundred day moving average price is $20.07. Bath & Body Works, Inc. has a one year low of $14.27 and a one year high of $33.96. The firm has a market cap of $3.51 billion, a PE ratio of 4.90, a price-to-earnings-growth ratio of 1.73 and a beta of 1.42.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same quarter last year, the company earned $0.49 EPS. The company’s revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Sell-side analysts expect that Bath & Body Works, Inc. will post 2.62 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is 22.47%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.